Stockreport

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics, Inc.  (SYRE) 
PDF WALTHAM, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneerin [Read more]